ABSTRACT
1993; Kendrick et al., 1996; Ishizuka et al., 2000; Matsuo et al., 2001) . However, typical microdialysis experiments sample the extracellular fluid in a time scale of minutes to tens of minutes, whereas NMDA receptor-mediated responses by glutamate occur within milliseconds and undergo desensitization and recovery in a time scale of seconds (Jones and Westbrook, 1996; Dingledine et al., 1999; Banke and Traynelis, 2003) .
In vivo voltammetry methods allow sufficient time resolution to detect real-time NO ⅐ release. However, in previous voltammetry studies aimed at measuring NO ⅐ (Malinski and Taha, 1992; Rivot et al., 1999) , the oxidation of accumulated nitrites could have contributed substantially to the measured NO ⅐ signal, as suggested by more recent studies (Crespi et al., 2001) . Clearly, measuring the accumulation of stable metabolites may preclude the detection of changes of NO ⅐ release in response to dynamic modifications of excitatory transmission or NMDA receptor function.
Thus, by using a selective and direct voltammetry method that allows the real-time measurement of NO ⅐ in vivo (Crespi et al., 2001) , we examined the changes in NO ⅐ release in response to chemical stimulation of NMDA receptors. We measured the NMDA-induced NO ⅐ formation in the extracellular fluid of the rat striatum in vivo under physiological conditions, after repeated NMDA receptor stimulation or after pharmacological manipulations affecting excitatory neurotransmission.
Materials and Methods

Animal Preparation
Experiments on animals were carried out in accordance with the European Community Council Directive (86/609/ECC) for the Care and Use of Laboratory Animals and were approved by the animal Care Committee of Cagliari University and GlaxoSmithKline.
Male Sprague-Dawley rats (Harlan, Italy) weighing 250 to 275 g, housed under conditions of constant temperature, humidity, dark/ light (12/12-h) cycle, and free access to food and water, were used in this study.
Voltammetric Analysis
Potentiostat System. The three-electrode potentiostat system used for voltammetry was prepared as described previously. Briefly, the reference electrode was silver/silver chloride and the auxiliary (counter) electrode was a silver wire, both approximately 100 m in diameter. The microsensor was a 30-m-diameter carbon fiber microelectrode (mCFE) prepared and treated as described previously (Crespi, 1991) to increase the sensitivity, selectivity, and reliability. Briefly, a 70-Hz triangular waveform was applied in three stages: 0 to ϩ2.2 V for 8 s, 0 to ϩ1.8 V for 10 s, and 0 to ϩ1.2 V for 10s. Two successive, continuous potentials were then applied: ϩ1.0 and Ϫ0.5 V, for 4 s each. This electrochemical treatment was carried out with the auxiliary, reference, and working electrodes immersed in 0.1 M phosphate-buffered saline (PBS) at pH 7.4. This treatment affects the active part of the working electrode, i.e., the tip of the protruding carbon fiber from the end of the glass pipette (30 m in diameter, 500 m in length; Fig. 1A ).
Amperometric Analysis of NO ⅐ and Nitrites in Vitro. Selective direct current amperometric analyses of NO ⅐ or nitrites were performed at ϩ550 or ϩ700 mV, respectively, according to the parameters described in a previous study (Crespi et al., 2001) . Briefly, the voltage was increased instantaneously to the potential selected, and the current was measured in time intervals of 0.2 s.
These analyses were applied by means of a AUTOLAB II polarograph (Eco Chemie, Utrecht, The Netherlands) linked to an IBM PC computer equipped with a General Purpose Electrochemical System Software package. NO ⅐ (6.6 M, as based on a saturated stock solution of 2 mM) and sodium nitrite (50 or 100 M) were tested either as soon as prepared, or after 60 min of exposure to air. In particular, NO ⅐ or nitrites were added to the buffer solution (PBS, pH 7.4, at room temperature) during the voltammetric scan to limit decay processes associated with autooxidation of NO ⅐ .
Analysis of NO ⅐ in Vivo. For in vivo voltammetric studies, rats were anesthetized (urethane, 1.2 g/kg i.p.) and held in a Kopf stereotaxic frame throughout the experiments. Two small adjacent holes (300 m in diameter) were drilled in the occipital bone. Reference and auxiliary electrodes were positioned between the bone and the dura. The measuring electrode, mCFE, was positioned into the striatum under a stereomicroscope, with coordinates: AP, 1.2; ML, 2.5; and DV, 4.5 mm from bregma (Paxinos and Watson, 1986) , as described previously (Crespi et al., 2001) (Fig. 1B) . Amperometric measurements (scans) were then performed, each scan lasting 300 s. Before the start of each experiment and at its completion, 1 l of a saturated solution of NO ⅐ (approximately 2 mM) dissolved in artificial cerebrospinal fluid (aCSF) was injected in the striatum as a control for the proper functioning of the mCFE system.
Drugs and Treatments
NO ⅐ , sodium nitrite (Carlo Erba, Milan, Italy), NMDA, D-(Ϫ)-2-amino-5-phosphonopentanoic acid (AP-5), N -nitro-L-arginine methyl ester (L-NAME) (all from Tocris Cookson Inc., Cambridge, UK) and glycine (Sigma-Aldrich, St. Louis, MO) were dissolved in aCSF and were injected locally into the striatum in a volume of 1 l/30 s. Each injection was performed during the amperometric scan via a Hamilton needle (100 m in diameter) inserted under light microscopy into the striatum at a distance of approximately 250 m from the mCFE. Dizolcipine maleate (MK801; Tocris Cookson Inc.) was injected systemically (i.p.) in a volume of 1 ml/kg.
Histology
At the end of each experiment, a direct current of 5 V was applied through the active tip of the mCFE to produce a lesion of the surrounding brain tissue. The brain was rapidly removed and sectioned using a cryostat. Sections (60 m) were stained using the Nissl solution and observed under light microscopy to confirm the correct position of the active tip of the microbiosensor.
Statistical Analysis
ANOVA followed by Bonferroni's multiple comparison test was used to calculate the statistical significance of differences of the neurochemical data.
Results
Detection of NO ⅐ in Vitro and in Vivo. In vitro. At a potential of ϩ550 mV and at room temperature, the addition during the scan of different amount of saturated (2 mM) NO ⅐ solution in PBS (final concentration, 1.8 or 3 M) to a well containing 3 ml of PBS resulted in the occurrence of an amperometric signal. The amplitude of the signal was concentration dependent (135 Ϯ 22 or 25 Ϯ 8 nA over baseline current, respectively; means Ϯ S.E.M., n ϭ 5, representative trace, Fig. 2a ). In contrast to NO ⅐ , the addition of 100 M sodium nitrite, as well as that of PBS produced no significant modification of basal current levels at this potential (n ϭ 5; representative trace, Fig. 2b) . Similarly, at this potential the addition of a NO ⅐ solution (3 M final) exposed to air for 1 h beforehand ("old NO ⅐ ") failed to affect basal amperometric current (n ϭ 5, representative trace, Fig. 2c ). On the other hand, when the potential was raised from ϩ550 to ϩ700 mV, the addition of nitrites either in a freshly prepared or "1-hold" solution gave rise to an amperometric signal with shape and duration markedly different from that generated by NO ⅐ at all potentials. Indeed, the current increased from baseline (2.0 Ϯ 0.3 nA), reaching prolonged plateau levels (4.5 Ϯ 0.9 nA; means Ϯ S.E.M., n ϭ 5, representative trace, Fig. 2d ). The addition of the substances was made after baseline stabilization after the typical initial drop of the amperometric current associated with the equilibration of the sensor (Bond, 1980 ) (for example, see Fig. 2 
, b-d).
In vivo. Similarly to in vitro experiments, at a potential of ϩ550 mV the application in the striatum of 1 l of 3 M exogenous NO ⅐ caused the occurrence of a sharp and transient amperometric signal (Fig. 2e) . Typically, the signal occurred about 5 s after the injection, had an intensity of 20 Ϯ 7 nA, and a peak width at half height of 10 Ϯ 2 s (means Ϯ S.E.M., n ϭ 5). Analysis of the disappearance of signal according to one-component, first-order kinetics gave a half-life value of 1.9 s. In contrast, the injection in the rat striatum of 100 M sodium nitrite (Fig. 2e) or that of old NO ⅐ (a NO ⅐ solution exposed to air for 1 h; data not shown) failed to change the basal amperometric current.
NMDA-Induced NO ⅐ Release in Vivo. Injection of vehicle (aCSF, 1 l) in the striatum of the anesthetized rat caused no change in baseline oxidation current (Fig. 3A) . The application of NMDA caused the rapid formation of a sharp and transient oxidation signal (Fig. 3A) . The NMDA-induced NO ⅐ signal occurred about 10 s after the injection and lasted for about 20 s. Kinetics analysis of the peak decay according to a one-component exponential decay function gave a k ϭ 0.06 s Ϫ1 and a half-life of 11.3 s. The NMDA-induced effect was concentration-dependent (10 -500 M) with an EC 50 of 48.5 M, as assessed by nonlinear regression analysis of the intensity of the signal versus the log of NMDA concentration according to a sigmoid function (Fig. 3B ). The inset in Fig. 3B shows the curve fitting of the raw data for the concentration-response relationship according to a square hyperbolic equation. In concentrationresponse studies, NMDA was injected consecutively at intervals of 60 min to avoid possible artifacts due to desensitization of the NMDA-induced response (see below).
Inhibition of NMDA-Induced NO ⅐ Release by L-NAME or NMDA Receptor Antagonists. To characterize the nature of the endogenous signal evoked by NMDA injection in vivo, we assessed the effect of the NOS inhibitor L-NAME on the NMDA-induced response. Groups of rats were pretreated with aCSF (vehicle, 1 l; n ϭ 4) or with 100 M L-NAME (1 l; n ϭ 4) locally in the striatum, and after 10 min, animals received a local injection of 100 M NMDA as described above. The addition of the NOS inhibitor prevented the occurrence of the oxidation signal, whereas pretreatment with vehicle did not (Fig. 4, left) . The application of L-NAME alone had no significant effect on baseline oxidation current (data not shown).
Under conditions similar to those of the previous experiment, application to another group of four rats of the competitive NMDA receptor antagonist AP-5 (1 l, 100 M) 10 min beforehand, suppressed the NMDA (100 M)-induced NO ⅐ electrochemical signal. The inhibition of the NMDA response was transient, because a challenge of NMDA, administered 60 min after the first injection, completely resumed the NO ⅐ signal (Fig. 4, right) . Similarly, systemic treatment with the noncompetitive NMDA receptor antagonist dizocilpine 20 min beforehand (1 mg/kg i.p.; n ϭ 4) suppressed the NMDA-induced NO ⅐ signal. The reduction of the NMDAinduced response was statistically significant [one-way ANOVA: F 12,3 ϭ 42.1; p Ͻ 0.0001]. The inhibitory effect of L-NAME or dizocilpine on the NMDA-induced response was long-lasting because the NMDA challenge produced no electrochemical signal 60 or 70 min after the first NMDA injection, respectively [ANOVA: F 12,3 ϭ 47.5; p Ͻ 0.0001; Fig. 4 , right].
Desensitization of NMDA-Induced NO ⅐ Release. Repeated local injections of NMDA (100 M) at 30-min inter- vals produced similar amperometric responses. However, when the injection interval was reduced to 80 to 90 s, a rapid decline of the amperometric signal was observed (Fig. 5) . A further NMDA challenge performed 60 min after the last of the consecutive injections resumed the appearance of an NO ⅐ signal with intensity virtually identical to that generated by the first NMDA application (Fig. 5A) .
Nonlinear regression analysis according to a one-compo- A signal was generated at the potential of ϩ550 mV by the addition to PBS of 3 or 1.8 M freshly prepared NO ⅐ solution (trace a). In contrast, no signals were detected at ϩ550 mV after the addition of 100 M sodium nitrite (NO 2 Ϫ ) or PBS (trace b) or the addition of 3 M NO ⅐ exposed to air for 1 h beforehand (old NO ⅐ , trace c). At ϩ700 mV, the addition of sodium nitrite caused an elevation of the oxidation current (trace d). In vivo, at ϩ550 mV, the application of freshly prepared 3 M NO ⅐ (1 l) through the injection needle in the striatum of the anesthetized rat caused the appearance of a sharp amperometric signal that was almost instantaneously monitored by the mCFE (trace e). At this potential, the injection in the brain of 1 l of 100 M sodium nitrite had no significant effect on baseline current. In some traces (b-d), the initial deflection of the current baseline reflects the stabilization of the measuring electrode in the medium (Bond, 1980) . (Fig. 6) . However, the coadministration of glycine 100 or 50 M with 100 M NMDA (n ϭ 4 for each group) caused a significant increase of the NMDA-induced NO ⅐ signal to 185 and 145%, respectively [ANOVA: F 3,16 ϭ 77.5; p Ͻ 0.0001], compared with the effect of NMDA alone (100%, 2.2 Ϯ 0.3 nA) (Fig. 6 ).
Discussion
The preliminary experiments in vitro confirm that the amperometric method used in this study detects NO ⅐ and that the oxidation signal is well separated from that of nitrites (Crespi et al., 2001) . In striatal tissue, the application of exogenous NO ⅐ caused the appearance of an oxidation signal with the electrochemical properties virtually identical to that obtained in vitro, further evidence that the system detects NO ⅐ also in vivo. Unknown electroactive species are unlikely to contribute to the NO ⅐ signal at ϩ550 mV because differential pulse voltammetry studies detected no oxidation current between ϩ400 and ϩ600 mV (Crespi, 1991) . The rate of decay of the NO ⅐ signal in the striatum was 1.9 s. This value is at the lower edge of the range reported in the literature (0.5-120 s) for oxygenated solutions or tissues by using several analytical techniques (e.g., stopped-flow absorption, chemiluminescence, colorimetry, and electrochemistry) (Kelm et al., 1988; Moncada et al., 1989; Ford et al., 1993; Wink et al., 1993; Kharitonov et al., 1994; Lewis and Deen, 1994; Wood and Garthwaite 1994; Goldstein and Czapski, 1995; Crespi et al., 2001) . Moreover, our calculated value in tissue is likely overestimated because it does not account for the initial diffusion that occurs during the injection. A very small half-life is expected in vivo, because reactions with biological molecules and uptake processes occur in the brain between the site of application and the biosensor. Accordingly, hemoglobin, the primary scavenger of NO ⅐ (Beckman and Koppenol, 1996) , provides an efficient mechanism for shortening NO ⅐ half-life.
From the time between the injection and the appearance of the signal (ϳ5 s) and the distance between the injection needle and the mCFE (ϳ250 m), we evaluated in 50 m/s Fig. 4 . Inhibition of NOS by L-NAME or blockade of NMDA receptors by AP-5 or dizolcipine prevents NMDA-induced striatal NO ⅐ release. Vehicle (1 l locally in the striatum or 2 ml/kg i.p.), L-NAME, AP-5 (1 l, 100 M locally in the striatum), or dizocilpine (1 mg/kg i.p.) were administered before the NMDA challenge (1 l, 100 M) at the time indicated below each column. Columns are means Ϯ S.E.M. from four rats per group. ‫,ء‬ p Ͻ 0.001 compared with vehicle-pretreated rats. ANOVA followed by Bonferroni's multiple comparison test. the velocity of diffusion in tissue. Thus, in brain NO ⅐ diffuses quickly and in spite of its short half-life can spread out from the site of generation over considerable distances and affect a large number of structures (a sphere with radius of 250 m corresponds approximately to a volume of 65 l). Notwithstanding the assumptions made in our calculations, our results are in striking agreement with theoretical predictions (Wood and Garthwaite, 1994) .
The application of NMDA in the striatum of the anesthetized rat caused a rapid, concentration-dependent release of NO ⅐ . Indeed, the NMDA receptor complex is physically coupled to the Ca 2ϩ -activated enzyme neuronal NOS (Sheng and Pak, 2000) , and several reports have shown an accumulation of nitrites in the extracellular matrix in vivo after NMDA treatment (Luo et al., 1993; Kendrick et al., 1996; Meyer et al., 1998; Rivot et al., 1999) . Concentration-response analysis for the NMDA effect gave an EC 50 of 48 M (Fig. 3B) . At this concentration, NMDA generates an NO ⅐ peak with an area 20 times smaller than that produced by the injection of 3 pmol of NO ⅐ . However, it is impossible to calculate the tissue NO ⅐ concentration at the site of injection because the volume in which NMDA diffuses in the tissue is unknown.
In agreement with other studies, the suppression of the NMDA-induced NO ⅐ release by the NOS inhibitor L-NAME is evidence that the signal detected in vivo is secondary to activation of NO ⅐ synthesis in the striatum (Fig. 4) . Furthermore, the inhibition of the NMDA-induced NO ⅐ release by competitive (AP-5) or noncompetitive (dizocilpine) NMDA receptor antagonists, confirms the role of NMDA receptors in the activation of the central NO ⅐ system resulting in increased synthesis and release. The long-lasting inhibition of the NMDA-induced NO ⅐ response by dizocilpine, compared with that of AP-5, is also consistent with the relatively long half-life of the drug. Thus, the NMDA-induced oxidation signal reflects the expected pharmacology and neurochemistry of NO ⅐ . The cellular source of NO ⅐ , however, is unknown. NMDA receptors are widely distributed. They are located on striatal medium spiny neurons (the primary target of corticostriatal projections), on neuronal terminal afferences, and on glial cells, and there is also evidence for extrasynaptic location. In addition, stimulation of NMDA receptors is associated with NO ⅐ -dependent elevations of extracellular levels of glutamate (Bogdanov and Wurtman, 1997) , an event that can contribute further to nonspecific depolarization.
On the other hand, the pulsatile nature of the NMDAinduced response was unexpected. Indeed, the accumulation of nitrites as assessed by microdialysis occurs over minutes or tens of minutes (Luo et al., 1993; Meyer et al., 1998; Rivot et al., 1999) . Because of their larger size and polarity, NMDA molecules diffuse slower from the site of application than NO ⅐ , a process expected to increase the number of NO ⅐ sources and cause more prolonged generation of NO ⅐ . This should give rise to a signal much broader than that produced by the application of exogenous NO ⅐ . The sharpness of the signal suggests the presence of feedback processes that rapidly switch off NO ⅐ formation. A first mechanism could be the reversible product inhibition of brain NOS by NO ⅐ . Studies in vitro show that NO ⅐ inhibits NOS at concentrations of 10 M (Rogers and Ignarro, 1992) or higher (Rengasamy and Johns, 1993) . However, our data indicate that it is unlikely that such levels of NO ⅐ can be reached at the injection site. Second, NO ⅐ can react with thiol groups on the receptor modulatory site, thereby desensitizing NMDA receptors (Lei et al., 1992; Manzoni et al., 1992) . A third contributing factor to the fast disappearance of the signal could involve desensitization of the NMDA receptor complex by a train of repeated NMDA applications. It is known that NMDA receptors desensitize in the continuous presence of an agonist (Jones and Westbrook, 1996) . Single channel kinetics studies indicate that the halflife of NMDA receptor desensitization falls in the range between 0.6 and 1.2 s (Dingledine et al., 1999; Banke and Traynelis, 2003) . In the present study, analysis of the NMDA-induced NO ⅐ signal gives a decay half-life of 11.3 s. Again, this value is largely overestimated because it does not account for the diffusion of NMDA in the tissue or for the time needed for the injection. It is possible, therefore, that feedback inhibition of NMDA-receptor function may contribute to the switch off of the NMDA-induced NO ⅐ formation. The fact the repeated NMDA (100 M) applications cause progressive reductions of the response (Fig. 5) indicates that the factors contributing to the inhibition of NMDA-induced NO ⅐ release can operate in vivo over a time range of minutes (decay half-life, 1.36 min). If this hypothesis is correct, our findings are first neurochemical evidence in vivo for desensitization of NMDA receptor-mediated NO ⅐ response. We can rule out possible contributions of neurotoxic effects by repeated NMDA applications because full recovery of the response occurs within 60 min from the last injection (Fig. 5A) . Thus, the apparent discrepancy between the present results and those of previous microdialysis studies is likely due to differences in the time scale of the sampling of the extracellular fluid (i.e., fractions of seconds in our electrochemical method compared with tens of minutes) and in the nature of the species measured (fleeting NO ⅐ compared with stable accumulated nitrites).
Regardless of the mechanism(s) involved, the desensitization of NO ⅐ response can have relevance to the physiological and pharmacological regulation of NMDA receptor-mediated glutamate neurotransmission (Jones and Westbrook, 1996) . In particular, they can have important implications for the excitotoxic effects of NOS activation (Stamler et al., 1992) secondary to NMDA receptor overreactivity as well as for the "paradoxical" neuroprotective role of NO ⅐ in neurodegeneration (Connop et al., 1995; Kendrick et al., 1996) .
A further outcome of the present study is the effect of glycine on NMDA-induced NO ⅐ release. Glycine is a coagonist of the NMDA receptor (Kleckner and Dingledine, 1988) , and previous reports that NMDA receptors can be activated by glycine alone Kutsuwada et al., 1992) have not been confirmed or disproved. The present results show that glycine has no effect on NO ⅐ formation in vivo, but it can enhance the NMDA-induced response. This result apparently extends to the NMDA receptor-dependent activation of the NO ⅐ pathway the notion that binding of the coagonist to its recognition site on the NR1 subunit (Dingledine et al., 1999) does not significantly affect the NMDA receptor function unless the receptor is in an activated state. However, we must point out that this response was elicited by concentrations of glycine that were at least an order of magnitude higher than the physiological concentrations in brain tissue. Further studies are needed to assess whether pharmacological manipulations of the glycine-binding site can modulate NMDA receptor-induced NO ⅐ release or affect its rate of desensitization (Lester et al., 1990) .
In conclusion, the present results show that NO ⅐ is instantly generated by NMDA receptor activation and rapidly travels over relatively long distances in brain tissue. The activation of the NO ⅐ system is transient, shuts off quickly, and undergoes desensitization. To the extent of NO ⅐ release can represent a dynamic neurochemical correlate of NMDA receptor function, its detection will be useful to assess in a time scale of seconds the state of excitatory transmission in vivo under physiological, pharmacological, or pathological conditions involving the function or dysfunction of the NMDA receptor-mediated glutamate neurotransmission.
